CardioExchange Archive

March 15th, 2010

Follow Along with Your Colleagues at the ACC, Day 2

Andrew M. Kates, MD

See previous post (ACC Day 1) and the following one (ACC Day 3) Several Fellows in Cardiology who are attending this week’s ACC meeting are blogging together right here. The Fellows include Shane LaRue, Justin Bachmann, Nihar Desai, Shanti Bansal, and Hansie Mathelier. Check back often to learn about the biggest buzz at the ACC — […]

---

March 14th, 2010

Does Fenofibrate ACCORD with the Treatment of Diabetes?

henrynginsberg and Andrew M. Kates, MD

CardioExchange welcomes Dr. Henry N. Ginsberg to discuss the findings of the ACCORD Lipid Study Group. In this paper, researchers randomized 5,500 diabetic patients to fenofibrate therapy versus placebo. All patients received simvastatin. Although triglyceride levels improved markedly with fenofibrate, the incidence of cardiovascular events was not affected.  CardioExchange Editors: Should we abandon fenofibrate for treating […]

---

March 13th, 2010

Follow Along with Your Colleagues at the ACC, Day 1

Andrew M. Kates, MD

See Next Post (ACC Day 2) Several Fellows in Cardiology who are attending this week’s ACC meeting are blogging together right here. The Fellows include Shane LaRue, Justin Bachmann, Nihar Desai, Shanti Bansal, and Hansie Mathelier. Check back often to learn about the biggest buzz at the ACC — whether it’s a poster, a presentation, or […]

---

March 1st, 2010

What Should the Relationship Be Between Pharmaceutical Companies and Fellows?

Andrew M. Kates, MD

Recent publications, including a scientific advisory in Circulation on rosiglitazone, the industry response to a Senate Finance Committee’s report on the drug, as well as a commentary in Forbes by Harlan Krumholz, have made me consider further the role that pharmaceutical companies play in the context of fellowship training programs. The relationships between training programs and these […]

---

January 15th, 2010

Evaluations

Andrew M. Kates, MD

This Journal Watch summary of a recent article from the New England Journal of Medicine made me consider further an issue that seems to be all-consuming: evaluations. In training programs across the country, we are required to give and receive evaluations on a regular basis. The goal, at least in part, seems straightforward enough — trainees require feedback to effectively […]

---

December 16th, 2009

New Guidelines

Andrew M. Kates, MD

How closely do you watch for new guidelines? It seems as if every week new guidelines are published on a variety of topics including atrial fibrillation, valve disease, STEMI and NSTEMI, and, most recently, the use of perioperative beta blockers.  Between guidelines, appropriateness criteria and various position papers, it can be extremely challenging to keep abreast of the most […]

---

November 17th, 2009

Residency work hours

Andrew M. Kates, MD

Apropos of our recent blog on work hours, see this post in the Boston Globe. What are your thoughts? If a reputable program goes on probation, how would this effect your willingness to apply? How do you feel about educational changes — including limiting conferences so that programs may be more compliant?

---

November 10th, 2009

Duty Hours – What are your thoughts?

Andrew M. Kates, MD

Fellows: Do you feel like you spend too much — or not enough — time in the hospital? Over the last several years, there have been dramatic changes to the number of hours that residents and fellows are permitted to spend in the hospital during a given period of time, during both the day and […]

---

November 6th, 2009

Darbepoetin–Trick or Treat? Part II

philipmarsden and Andrew M. Kates, MD

(SEE PART 1 OF SERIES) I was amazed by three things when the results from Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) were presented Friday October 30th, 2009 at the American Society of Nephrology Annual Meeting in San Diego: Thousands of atttendees came to hear TREAT presented by Dr M. Pfeffer–The room was tense […]

---

November 6th, 2009

This May Be of Interest…

Andrew M. Kates, MD

Along with James, I would like to welcome you to this new endeavor. One of our goals for this site is to provide fellows with access to important articles — be they cutting-edge technology or reviews of important issues within cardiology — from a wide array of sources. We may refer to stories from various journals as well as the other areas of CardioExchange. On the prevention group […]

---